A
Agnieszka Ługowska
Publications - 50
Citations - 802
Agnieszka Ługowska is an academic researcher. The author has contributed to research in topics: Metachromatic leukodystrophy & Arylsulfatase A. The author has an hindex of 16, co-authored 47 publications receiving 654 citations.
Papers
More filters
Journal ArticleDOI
Non-neuronopathic Gaucher disease due to saposin C deficiency
Anna Tylki-Szymańska,Barbara Czartoryska,Marie T. Vanier,B. J. M. H. Poorthuis,J. A. E. Groener,Agnieszka Ługowska,Gilles Millat,Anna Maria Vaccaro,Elżbieta Jurkiewicz +8 more
TL;DR: The presented findings describe the first cases where the non‐neuronopathic Gaucher disease has been definitely demonstrated to be a consequence of SAP‐C deficiency.
Journal ArticleDOI
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia
Małgorzata Bednarska-Makaruk,Ałła Graban,Anna Wiśniewska,Wanda Łojkowska,Anna Bochyńska,Magdalena Gugała-Iwaniuk,Ksenia Slawinska,Agnieszka Ługowska,Danuta Ryglewicz,Hanna Wehr +9 more
TL;DR: Dementia of neurodegenerative origin is characterized by elevated adiponectin levels, whereas dementia with vascular changes by increase of resistin is concluded, suggesting association with inflammatory indicators may suggest the pro-inflammatory role ofresistin in the development of dementia.
Journal ArticleDOI
Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.
Journal ArticleDOI
Prevalence rates of mucopolysaccharidoses in Poland
TL;DR: The prevalence pattern of mucopolysaccharidosis in Poland is lower when compared to the prevalence reported for other European countries, such as the Netherlands, Czech Republic, or Germany, but similar to countries like Sweden and Denmark.
Journal ArticleDOI
Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation - a novel phenotype of the mitochondrial disease.
Hanna Mierzewska,Małgorzata Rydzanicz,T Biegański,Joanna Kosińska,Magdalena Mierzewska-Schmidt,Agnieszka Ługowska,Agnieszka Pollak,Piotr Stawiński,Anna Walczak,Anna Kędra,Ewa Obersztyn,Elżbieta Szczepanik,Rafał Płoski +12 more
TL;DR: SEMD is placed as the third instance of a skeletal phenotype associated with a mitochondrial disease (the others being EVEN‐PLUS syndrome caused by mutations of HSPA9 and CODAS syndrome due to LONP1 mutations).